Shots: With the implementation of the Inflation Reduction Act (IRA) in 2022, several pricing reforms were introduced, including the new mandated drug pricing and discount elements Today, we have with us Gavin Magaha, Senior Director, Value Delivery for Kalderos, shedding light on the challenges that come with the IRA act and the impact it puts on…
Shots: Kyle Forcier, Sr. Director of Life Science Product Marketing at Model N, addresses the challenges of the 340B program and ways manufacturers can mitigate them and emerge stronger 340B, a US federal government plan, enables eligible healthcare organizations and covered entities to receive outpatient drugs from drug manufacturers at significantly low prices Kyle recalls…

